These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25496771)

  • 21. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR; Lazarus AH
    Semin Hematol; 2016 Apr; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).
    Machino Y; Ohta H; Suzuki E; Higurashi S; Tezuka T; Nagashima H; Kohroki J; Masuho Y
    Clin Exp Immunol; 2010 Dec; 162(3):415-24. PubMed ID: 21029072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
    Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
    J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
    Crow AR; Song S; Semple JW; Freedman J; Lazarus AH
    Blood; 2007 Jan; 109(1):155-8. PubMed ID: 16954498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody specific for the glycophorin A complex mediates intravenous immune globulin-resistant anemia in a murine model.
    Chen X; Ghaffar H; Jen CC; Lazarus AH
    Transfusion; 2014 Mar; 54(3):655-64. PubMed ID: 23782137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS; Sun DS; Lien TS; Chang HH
    Blood; 2010 Dec; 116(23):5002-9. PubMed ID: 20699442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia.
    Deng R; Balthasar JP
    J Pharm Sci; 2007 Jun; 96(6):1625-37. PubMed ID: 17238194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].
    Zhu Y; Zhuang Y; Yang GH; Qiang XF; Yang L; Shen YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):135-9. PubMed ID: 23484707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 antibodies and immune thrombocytopenia in the amelioration of murine inflammatory arthritis.
    Mott PJ; Lazarus AH
    PLoS One; 2013; 8(6):e65805. PubMed ID: 23785450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
    Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.
    Shimomura M; Hasegawa S; Seki Y; Fukano R; Hotta N; Ichiyama T
    Clin Exp Immunol; 2012 Jul; 169(1):33-7. PubMed ID: 22670776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.
    Tremblay T; Aubin E; Lemieux R; Bazin R
    Br J Haematol; 2007 Oct; 139(2):297-302. PubMed ID: 17897306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.